Education

Chemistry and Psychology

Career

Dr. Fabio Garofolo has been working in the pharmaceutical and analytical fields since 1989. Capitalizing on an extensive occupational background within his specialization field, he has also been involved to help scientific non-profit organizations (AAPS, ASMS, CFABS, CVG, GBC, GCC and NBC) with the mission to promote discussion on the pharmaceutical practices. Dr. Garofolo has progressed throughout in his career in both the pharma/biotech R&D and CRO industries and he is presently the Head of Research at Angelini Pharma. He has over 180 publications & presentations in international conferences. Dr. Garofolo developed over 400 innovative methods. He designed and invented 3 innovative bioanalytical approaches and is the recipient of the following Lilly awards: Achievement (2001); Global (2002); Emmerson (2003). His current interests include analysis of Large Molecules by Hybrid LBA/LCMS, HRMS, DBS, and LBA Emerging Technologies.

Works

• Other Work

  • Overcoming Matrix Effects - 20th International Reid Bioanalytical Forum

    ( )

  • Overcoming the Bioanalysis Challenges of Biosimilars: Rituximab Case Study
  • Challenges and Solutions in Large Molecule Quantification using LC-MS/MS
  • Large Molecule High Resolution Mass Spectrometry (HRMS) in Bioanalysis
  • DBS Dried Blood Spots in Toxicology: Overcome Regulatory Challenges - SOT 2014 - YouTube

References

• 2014 White Paper in Bioanalysis
• 2013 White Paper in Bioanalysis
• 2012 White Paper in Bioanalysis
• Overcoming the Bioanalysis Challenges of Biosimilars: Rituximab Case Study
• Challenges and Solutions in Large Molecule Quantification using LC-MS/MS
• Large Molecule High Resolution Mass Spectrometry (HRMS) in Bioanalysis
• DBS Dried Blood Spots in Toxicology: Overcome Regulatory Challenges - SOT 2014
• Overcoming Matrix Effect 20th International Reid Bioanalytical Forum